Skip to content

External Application of Chinese Medicine Alleviated Pain Caused by Bone Metastasis in Cancer Patients

External Application of Chinese Medicine Alleviated Pain Caused by Bone Metastasis in Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059082
Enrollment
Unknown
Registered
2022-04-24
Start date
2021-12-16
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone metastasis pain

Interventions

Exposure group:Zoledronic acid injection combined with external application of traditional Chinese Medicine

Sponsors

Huanxing Cancer Hospital,Chaoyang District,Beijing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? According to the diagnostic criteria, the metastatic site was accompanied by moderate pain (pain score vas = 4); ? The pain site is limited to the limbs, back and waist. The pain site is clear and fixed. It is suitable for external application treatment. The epidermis is is free of damage, redness, swelling and fever.

Exclusion criteria

Exclusion criteria: ? Have received systemic chemotherapy within 1 month, or the pain site of bone metastasis has been treated with radiotherapy or nerve block; ? Non cancerous pain, as often accompanied by tumor emergency related pain, or other tumor related neuralgia (such as postoperative incision pain, postherpetic neuralgia, etc.)

Design outcomes

Primary

MeasureTime frame
Pain relief PAR;Analgesic onset time;KPS;

Countries

China

Contacts

Public ContactYe Peizhi
xiaokaimen@126.com13671012908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026